Aspirin may reduce risk of breast cancer by a fifth
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Drugs like aspirin can reduce the risk of breast cancer by about 20 per cent, according to a review of studies published over the past 27 years.
Scientists analysed 21 studies involving more than 37,000 women and found an overall decreased risk for women taking nonsteroidal anti-inflammatory drugs (NSAIDs). They also discovered that they could play a role in treating women already diagnosed with breast cancer.
However, the researchers cautioned that more studies were needed on the ideal type of drug, dose and duration before there was any big push to get women to take the drugs routinely.
They also warned that more research was needed on whether any benefits outweighed side-effects in the long term. They concluded: "There may be a role for NSAIDs in combination with endocrine therapies as either an adjuvant or palliative treatment for women with established breast cancer."
Ian Fentiman, professor of oncology at Guy's and St Thomas' NHS Foundation Trust in London, carried out the study, published in the International Journal of Clinical Practice. He said: "Our review suggests that, in addition to possible prevention, there may also be a role for NSAIDs in treatment of women with established breast cancer. NSAID use could be combined with hormone therapy."
"NSAIDs may well offer protection against developing breast cancer in the first place and may provide a useful addition to treatment available to women who already have the disease. Recent studies of NSAIDs use have shown about a 20 per cent risk reduction in incidence of breast cancer, but this benefit may be confined to aspirin use alone and not other NSAIDs."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments